Where does Dreampath Diagnostics rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Dreampath Diagnostics ranks #46,285 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Dreampath Diagnostics hold?

Dreampath Diagnostics holds 5 US utility patents granted between 2016 and 2023, spanning 7 technology areas.

What is Dreampath Diagnostics's Innovation Score?

Dreampath Diagnostics has an Innovation Score of 33.1 out of 100 (43rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Dreampath Diagnostics focus on?

Dreampath Diagnostics's top technology area is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE) with 3 patents, ranking #582 of 1,325 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Dreampath Diagnostics's patent grant rate increasing or decreasing?

Dreampath Diagnostics's recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Dreampath Diagnostics's patents?

Dreampath Diagnostics's patents average 7.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Dreampath Diagnostics patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Dreampath Diagnostics

USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dreampath ranks #46,285 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 7 technology areas.

#46,285
of 49,997 US assignees by volume: 43rd percentile
by Innovation Score (33.1/100): 7.0
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R46285 · Foreign Corporation #46,285 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #46,285/49,997
PHOTO-FINISH DR HoldCo 2
CPC-NARROW B01L · 7 areas
INNOV-THIN 33.1/100
CLAIMS-SPARSE 7.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: DR HoldCo 2, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Dreampath’s 33.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (19%) Velocity 13.3 pts (40%) Breadth 9.4 pts (28%) Claim depth 4.2 pts (13%)

Qualcomm Incorporated · highest

85
Dreampath Diagnostics · this assignee

33
Gordon Murray… · near

33
Kuang-chi Intelligen… · near

33
Vidyo · near

33
Deborah Adler · near

33
3D Lighting… · lowest

7

What this shows Dreampath's Innovation Score is 33.1/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Dreampath?

Each dot is one of Dreampath’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dreampath’s own 7.0 claims/patent is at or below the 17.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Dreampath vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Dreampath's grants concentrate

Dreampath Diagnostics is a focused PatentsView assignee: 7 CPC subclasses with 60% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2016. By volume, Dreampath sits between DR HoldCo 2, Inc. and Drifire, LLC.

Dreampath's three-year grant acceleration

Dreampath Diagnostics shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

DR Holdco 2

5
Dragonchain

5
Dragonwave

5
Dreamlight Holdin…

5
Dreamvu

5
Dreem

5
Drever Internatio…

5
Drifire

5
Dreampath Diagnos… ◀

5

What this shows Dreampath holds 5 patents at rank #46,161, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Dreampath

By rank, the assignees closest to #46,161 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in Dreampath's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Dreampath, neither rank-band nor same-CPC leaders (those blocks stay above). In B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), Dreampath ranks #582 of 1,325 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (33 here).

Gordon Murray Automotive Limited 33 Kuang-chi Intelligent Photonic Technology Ltd. 33 Vidyo, Inc. 33 Deborah Adler LLC 33

Dreampath's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Dreampath Diagnostics patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	20.0%
2018	1	20.0%
2021	1	20.0%
2023	2	40.0%

Which technologies does Dreampath Diagnostics patent most?

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 3

A61B - DIAGNOSIS; SURGERY; Identification 3

G07F - Coin-freed OR Like Apparatus 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

B65G - Transport OR Storage Devices, e.g. Conveyors FOR Loading OR Tipping, Shop Conveyor Systems OR Pneumatic Tube Conveyors 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

G06K - Graphical Data Reading ; Presentation OF DATA; Record CARRIERS; Handling Record Carriers 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Dreampath Diagnostics's patent record in context - here's where to go next.

Dreampath Diagnostics's lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 60% of its portfolio - see every assignee active in that class. Explore B01L
Ranked #46,285 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Dreampath Diagnostics against DR HoldCo 2, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.